A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Clinical trial NCT04688021 · UNKNOWN

Trial details

NCT number: NCT04688021
Sponsor: Yi Luo
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Graft-versus-host-disease

Start date: 2020-12-03
Primary completion: 2024-12-03
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.